Research and Development

Showing 15 posts of 9596 posts found.

Working Life: Carlos Gallardo, general manager, Almirall

February 2, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Carlos Gallardo

BiographyCarlos Gallardo is general manager of the Almirall UK and Ireland affiliate from its creation in 2008. He has an …
AstraZeneca picture

AstraZeneca to cut 7,300 jobs as growth stalls

February 2, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AZ, AstraZeneca, David Brennan, R&D

AstraZeneca will make 7,300 cuts to its sales and R&D staff by 2014, but the company has not yet said …

Sigma-Aldrich acquires testing company BioReliance

February 1, 2012 Research and Development Sigma-Aldrich

Sigma-Aldrich has acquired clinical testing company BioReliance for $350 million. Purchased from Avista Capital Partners, BioReliance provides services that include …

Dietmar Leitner joins Napp Pharmaceuticals as its new managing director

January 31, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Dietmar Leitner, Napp Pharmaceuticals

Dietmar Leitner has been appointed managing director of Napp Pharmaceuticals, part of the Napp Pharmaceutical Group.   Dietmar has worked …

Pfizer in talks on Sandwich site sale

January 30, 2012 Research and Development Pfizer, Sandwich

Pfizer has begun talks with a real estate investor to sell its R&D centre in Sandwich. The site was Pfizer’s …

James Murdoch steps down from GSK board

January 27, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, James Murdoch

GlaxoSmithKline has announced that after nine years with the firm, Sir Crispin Davis, Sir Robert Wilson and Larry Culp will …
Boehringer picture

Boehringer broadens afatinib studies

January 27, 2012 Research and Development, Sales and Marketing Boehringer Ingelheim, Cancer, afatinib

Boehringer Ingelheim is expanding the scope of its studies into afatinib to test its use against head and neck cancers. …
Amgen picture

Amgen buys Micromet for $1.2 billion

January 27, 2012 Research and Development, Sales and Marketing Amgen. Micromet, blinatumomab

Amgen is to buy German biotech firm Micromet for $1.16 billion to broaden its mid-stage pipeline and consolidate its oncology …

Bristol-Myers Squibb elects Gerald Storch to board of directors

January 26, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BMS, Gerald Storch

Bristol-Myers Squibb has announced that its board has elected Gerald Storch to serve as a member of the audit committee, …

CRAs spend less time on site, more time travelling

January 25, 2012 Research and Development CRAs, Clinical Research Associates, Tufts, clinical trials

A new study of how clinical research associates (CRAs) spend their time has produced some interesting and surprising results. The …

Cell-based assays to help speed toxicity studies

January 25, 2012 Research and Development Qiagen, cell-based assays, drug discovery

Use of cell-based assay technology is set to grow rapidly over the next decade, helping to speed up drug discovery …
Roche picture

Roche launches $5.7 billion hostile bid for Illumina

January 25, 2012 Research and Development, Sales and Marketing Diagnostics, Illumina, Roche

Roche has launched a hostile takeover bid for US diagnostics company Illumina. The Swiss manufacturer appears tired of waiting for …

Premier Research appoints Etienne Drouet as executive director, Oncology Europe

January 25, 2012 Business Services, Research and Development, Sales and Marketing Etienne Drouet, Premier Research

 Premier Research Group has announced the appointment of Etienne Drouet to the position of executive director, Oncology Europe.In this position, …

Gates urges investment in innovations for developing nations

January 25, 2012 Research and Development AIDS, Bill Gates, Global Fund, TB, malaria

Bill Gates has called on global leaders to invest in innovations that are accelerating progress against poverty, or risk a …
Lansley picture

Councils given £2.2 billion for public health

January 25, 2012 Research and Development, Sales and Marketing Lansley, NHS, public health outcomes framework

The government’s new vision for public health has come under fire from observers worried that accountability for the strategy remains …
The Gateway to Local Adoption Series

Latest content